|
KMID : 0366220170520010003
|
|
Korean Journal of Hematology
2017 Volume.52 No. 1 p.3 ~ p.6
|
|
|
The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective
|
|
Suh Cheol-Won
Park Byeong-Bae
Kim Won-Seog
|
|
|
Abstract
|
|
|
|
The Consortium for Improving Survival of Lymphoma (CISL) of the Korean Society of Hematology Lymphoma Working Party is a multicenter collaborative study group performing prospective clinical studies for lymphoma patients and retrospective analyses. Since 2006, the CISL has performed >35 prospective clinical trials and >30 retrospective studies to investigate the clinical and pathological features of lymphoma subtypes and the outcomes of new therapeutic modalities. The year 2016 is the 10th anniversary of the CISL, and this report aims to commemorate its progress during the past 10 years. The CISL previously reported its achievements between 2006 and 2012, including 32 publications as of the end of 2012. Herein, we summarize clinical studies conducted by the CISL from 2013 to 2015.
|
|
|
KEYWORD
|
|
|
Perspective
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|